Search

IndicationsAdalimumab is a tumor necrosis factor (TNF) blocker indicated for treatment of: - Rheumatoid Arthritis (RA): Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately t..